Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea
· Delayed Price · Currency is KRW 7,120.00
+10.00 (0.14%)
Feb 21, 2025, 9:00 AM KST
Seoulin Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 61,548 | 78,767 | 97,546 | 174,747 | 107,487 | 68,537 | Upgrade
|
| Market Cap Growth | -14.81% | -19.25% | -44.18% | 62.58% | 56.83% | -9.30% | Upgrade
|
| Enterprise Value | 39,289 | 46,863 | 48,995 | 136,075 | 93,693 | 49,869 | Upgrade
|
| Last Close Price | 7120.00 | 8862.64 | 10842.90 | 19192.91 | 11739.20 | 7361.56 | Upgrade
|
| PE Ratio | - | - | 9.60 | 11.21 | 21.97 | 7.71 | Upgrade
|
| PS Ratio | 0.76 | 0.88 | 0.93 | 2.17 | 1.65 | 1.26 | Upgrade
|
| PB Ratio | 0.73 | 0.92 | 1.10 | 2.28 | 1.75 | 1.12 | Upgrade
|
| P/TBV Ratio | 0.78 | 0.96 | 1.17 | 2.36 | 1.82 | 1.17 | Upgrade
|
| P/FCF Ratio | 53.75 | - | - | 21.89 | 32.74 | 9.72 | Upgrade
|
| P/OCF Ratio | 45.01 | 84.64 | - | 19.60 | 29.17 | 9.36 | Upgrade
|
| EV/Sales Ratio | 0.48 | 0.52 | 0.47 | 1.69 | 1.44 | 0.92 | Upgrade
|
| EV/EBITDA Ratio | 18.56 | 12.39 | 4.80 | 14.51 | 14.52 | 14.43 | Upgrade
|
| EV/EBIT Ratio | 47.79 | 18.79 | 5.33 | 18.26 | 20.96 | 27.66 | Upgrade
|
| EV/FCF Ratio | 34.31 | - | - | 17.04 | 28.54 | 7.07 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.08 | 0.20 | 0.21 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.87 | 1.78 | 1.74 | 1.68 | 0.12 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 1.54 | - | - | 1.97 | 0.23 | 0.04 | Upgrade
|
| Asset Turnover | 0.70 | 0.72 | 0.77 | 0.75 | 0.82 | 0.72 | Upgrade
|
| Inventory Turnover | 2.58 | 3.57 | 5.15 | 4.63 | 4.09 | 2.99 | Upgrade
|
| Quick Ratio | 2.75 | 1.77 | 1.35 | 1.44 | 2.13 | 1.93 | Upgrade
|
| Current Ratio | 4.98 | 2.60 | 1.88 | 1.77 | 3.06 | 2.78 | Upgrade
|
| Return on Equity (ROE) | -3.56% | -2.67% | 12.78% | 23.03% | 7.83% | 15.25% | Upgrade
|
| Return on Assets (ROA) | 0.39% | 1.25% | 4.23% | 4.34% | 3.52% | 1.48% | Upgrade
|
| Return on Capital (ROIC) | 0.47% | 1.57% | 5.78% | 6.03% | 4.52% | 1.90% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.85% | 2.90% | 10.32% | 9.66% | 6.91% | 2.77% | Upgrade
|
| Earnings Yield | -1.07% | -0.15% | 10.41% | 8.92% | 4.55% | 12.96% | Upgrade
|
| FCF Yield | 1.86% | -0.02% | -4.94% | 4.57% | 3.05% | 10.29% | Upgrade
|
| Dividend Yield | 1.34% | 1.08% | - | - | - | - | Upgrade
|
| Payout Ratio | 0.00% | - | 7.86% | 4.93% | 14.74% | 11.59% | Upgrade
|
| Buyback Yield / Dilution | 5.80% | 19.42% | -23.72% | 0.07% | 1.26% | 0.72% | Upgrade
|
| Total Shareholder Return | 7.14% | 20.50% | -23.72% | 0.07% | 1.26% | 0.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.